307 related articles for article (PubMed ID: 27764149)
1. miRNA Expression Profiles of HPV-Infected Patients with Cervical Cancer in the Uyghur Population in China.
Gao D; Zhang Y; Zhu M; Liu S; Wang X
PLoS One; 2016; 11(10):e0164701. PubMed ID: 27764149
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer.
Han MS; Lee JM; Kim SN; Kim JH; Kim HS
Biomed Res Int; 2018; 2018():1942867. PubMed ID: 30627542
[TBL] [Abstract][Full Text] [Related]
3. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.
Vojtechova Z; Sabol I; Salakova M; Smahelova J; Zavadil J; Turek L; Grega M; Klozar J; Prochazka B; Tachezy R
BMC Cancer; 2016 Jul; 16():382. PubMed ID: 27377959
[TBL] [Abstract][Full Text] [Related]
6. Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.
Nair VB; Manasa VG; Sinto MS; Jayasree K; James FV; Kannan S
Int J Gynecol Cancer; 2018 Mar; 28(3):553-562. PubMed ID: 29466255
[TBL] [Abstract][Full Text] [Related]
7. microRNA portraits in human vulvar carcinoma.
de Melo Maia B; Lavorato-Rocha AM; Rodrigues LS; Coutinho-Camillo CM; Baiocchi G; Stiepcich MM; Puga R; de A Lima L; Soares FA; Rocha RM
Cancer Prev Res (Phila); 2013 Nov; 6(11):1231-41. PubMed ID: 24048714
[TBL] [Abstract][Full Text] [Related]
8. Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.
Babion I; Snoek BC; Novianti PW; Jaspers A; van Trommel N; Heideman DAM; Meijer CJLM; Snijders PJF; Steenbergen RDM; Wilting SM
Clin Epigenetics; 2018; 10():76. PubMed ID: 29930741
[TBL] [Abstract][Full Text] [Related]
9. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29.
Li Y; Wang F; Xu J; Ye F; Shen Y; Zhou J; Lu W; Wan X; Ma D; Xie X
J Pathol; 2011 Aug; 224(4):484-95. PubMed ID: 21503900
[TBL] [Abstract][Full Text] [Related]
10. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
[TBL] [Abstract][Full Text] [Related]
11. Methylation and expression of miRNAs in precancerous lesions and cervical cancer with HPV16 infection.
Jiménez-Wences H; Martínez-Carrillo DN; Peralta-Zaragoza O; Campos-Viguri GE; Hernández-Sotelo D; Jiménez-López MA; Muñoz-Camacho JG; Garzón-Barrientos VH; Illades-Aguiar B; Fernández-Tilapa G
Oncol Rep; 2016 Apr; 35(4):2297-305. PubMed ID: 26797462
[TBL] [Abstract][Full Text] [Related]
12. Suppression of miR-93-5p inhibits high-risk HPV-positive cervical cancer progression via targeting of BTG3.
Li J; Chu ZP; Han H; Zhang Y; Tian F; Zhang JQ; Huang XH
Hum Cell; 2019 Apr; 32(2):160-171. PubMed ID: 30689165
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y;
World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598
[TBL] [Abstract][Full Text] [Related]
14. [The role of microRNAs in the pathogenesis of cervical cancer and its relationship to HPV].
Zhu YK; Cheng N; Hu Y; Cen YZ
Sheng Li Ke Xue Jin Zhan; 2012 Aug; 43(4):251-6. PubMed ID: 23189617
[TBL] [Abstract][Full Text] [Related]
15. Potentially prognostic miRNAs in HPV-associated oropharyngeal carcinoma.
Hui AB; Lin A; Xu W; Waldron L; Perez-Ordonez B; Weinreb I; Shi W; Bruce J; Huang SH; O'Sullivan B; Waldron J; Gullane P; Irish JC; Chan K; Liu FF
Clin Cancer Res; 2013 Apr; 19(8):2154-62. PubMed ID: 23459718
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance.
Yang Y; Xie YJ; Xu Q; Chen JX; Shan NC; Zhang Y
Gynecol Oncol; 2015 Sep; 138(3):683-8. PubMed ID: 26074491
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.
Martinez I; Gardiner AS; Board KF; Monzon FA; Edwards RP; Khan SA
Oncogene; 2008 Apr; 27(18):2575-82. PubMed ID: 17998940
[TBL] [Abstract][Full Text] [Related]
18. Novel MicroRNA signatures in HPV-mediated cervical carcinogenesis in Indian women.
Sharma S; Hussain S; Soni K; Singhal P; Tripathi R; Ramachandran VG; Sharma S; Das S; Pillai B; Bharadwaj M
Tumour Biol; 2016 Apr; 37(4):4585-95. PubMed ID: 26508022
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract][Full Text] [Related]
20. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]